IVVD · Invivyd, Inc.
$0.72
+0.04 (+5.13%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on current operating plans and excluding future external financing, we will not have sufficient cash and cash equivalents to fund our operating expenses and capital requirements beyond one year from the issuance date of the condensed consolidated financial statements in this Quarterly Report on Form 10-Q, and therefore, we have concluded that there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$212.49M
Shares
294.76M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding IVVD
36 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Eventide Healthcare & Life Sciences Fund | — | 9,071,995 | $11,793,594 | 0.74% | Long | 2026-03-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 7,392,820 | $9,610,666 | 0.00% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 5,654,625 | $7,351,013 | 0.10% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 2,371,004 | $3,082,305 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 1,103,785 | $1,258,315 | 0.00% | Long | 2026-05-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 571,661 | $743,159 | 0.00% | Long | 2026-03-31 | |
| Driehaus Micro Cap Growth Fund | — | 562,019 | $730,625 | 0.16% | Long | 2026-03-31 | |
| Emerald Growth Fund | — | 428,847 | $600,386 | 0.04% | Long | 2026-04-30 | |
| Invesco RAFI US 1500 Small-Mid ETF | — | 363,923 | $509,492 | 0.02% | Long | 2026-04-30 | |
| Direxion Daily S&P Biotech Bull 3X Shares | — | 329,668 | $461,535 | 0.09% | Long | 2026-04-30 | |
| Fidelity Total Market Index Fund | — | 390,357 | $445,007 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 323,967 | $369,322 | 0.00% | Long | 2026-05-31 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 172,414 | $224,138 | 0.00% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 170,004 | $193,805 | 0.00% | Long | 2026-05-31 | |
| VANGUARD BALANCED INDEX FUND | — | 136,616 | $177,601 | 0.00% | Long | 2026-03-31 | |
| Virtus Biotech Clinical Trials Etf | — | 118,970 | $166,558 | 0.45% | Long | 2026-04-30 | |
| Schwab Total Stock Market Index Fund | — | 117,920 | $165,088 | 0.00% | Long | 2026-04-30 | |
| BIOTECHNOLOGY ULTRASECTOR PROFUND | — | 102,029 | $142,841 | 0.08% | Long | 2026-04-30 | |
| LVIP State Street Small-Cap Index Fund | — | 158,100 | $137,926 | 0.01% | Long | 2026-06-30 | |
| Ultra-Small Company Market Fund | — | 93,400 | $121,420 | 0.10% | Long | 2026-03-31 | |
| TIFF MULTI-ASSET FUND | — | 45,294 | $58,882 | 0.00% | Long | 2026-03-31 | |
| Small-Cap Index Portfolio | — | 61,594 | $53,735 | 0.01% | Long | 2026-06-30 | |
| PROFUND VP BIOTECHNOLOGY | — | 31,477 | $40,920 | 0.10% | Long | 2026-03-31 | |
| Victory Extended Market Index Fund | — | 25,703 | $35,984 | 0.00% | Long | 2026-04-30 | |
| Amplify Treatments, Testing and Advancements ETF | AIEQ | 26,457 | $29,103 | 0.32% | Long | 2024-06-30 | |
| Goldman Sachs Absolute Return Tracker Fund | — | 20,809 | $27,052 | 0.00% | Long | 2026-03-31 | |
| Invesco Nasdaq Biotechnology ETF | — | 14,607 | $16,652 | 0.02% | Long | 2026-05-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 12,100 | $15,730 | 0.00% | Long | 2026-03-31 | |
| PD Small-Cap Value Index Portfolio | — | 16,145 | $14,085 | 0.01% | Long | 2026-06-30 | |
| ProShares Ultra Nasdaq Biotechnology | — | 10,244 | $11,678 | 0.02% | Long | 2026-05-31 | |
| Small-Cap Equity Portfolio | — | 8,891 | $7,757 | 0.00% | Long | 2026-06-30 | |
| Total Stock Market Index Trust | — | 4,475 | $5,818 | 0.00% | Long | 2026-03-31 | |
| Small-Mid Cap Equity Fund | MSLC | 5,339 | $3,730 | 0.00% | Long | 2024-11-30 | |
| State Street Balanced Index Fund | — | 2,516 | $3,271 | 0.00% | Long | 2026-03-31 | |
| Knights of Columbus U.S. ALL CAP INDEX FUND | — | 1,289 | $1,805 | 0.00% | Long | 2026-04-30 | |
| U.S. Small Cap Equity Fund | — | 11,908 | $16,671 | 0.00% | Short | 2026-04-30 |
Showing 1–36 of 36 positions
Key facts
CIK
1832038
CUSIP
00534A102
13F (30d)
128 filings
125 filers
Visit website
Investor relations